The Kenya Association of Pharmaceutical Industry (KAPI) on Thursday confirmed its support for a global initiative geared at addressing the rise of non-communicable diseases (NCDs).
The initiative, launched on Wednesday at the ongoing World Economic Forum in Davos, Switzerland, will see 22 leading bio-pharmaceutical companies joining hands to advance access to NCDs prevention and care agenda in low and lower-middle income countries including Kenya.
Speaking in Nairobi to confirm the local association’s support for the new initiative dubbed “Access Accelerated”, KAPI Spokesperson William Mwatu said the program will provide much-needed impetus to facilitate sustainable NCD management.
“The KAPI membership acknowledges that NCDs have reached a point of crisis, particularly in lower and middle income countries, where nearly 80 percent of NCD-related deaths occur,” Mwatu said.
The KAPI membership, he said, will provide the necessary support to ensure the initiative get off the ground.
The goal of Access Accelerated, launched in partnership with the World Bank Group and the Union for International Cancer Control (UICC), is to work toward the UN Sustainable Development Goal (SDG) target to reduce premature deaths from NCDs by one third by 2030. Enditem